VivoSeq
Musculoskeletal

Bursitis

17

Pipeline Programs↗

2

Active Trials↗

15

Companies Involved↗

Bursitis is an emerging landscape with 17 programs across 15 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, APR Applied Pharma Research s.a., Pacira Pharmaceuticals, Inc. 6 therapies are approved with 2 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

44/100

Pipeline Velocity

0/100

Mech. Concentration

42/100

Completion Rate

93/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Vitae Pharmaceuticals Inc., an Allergan affiliate

1 program

Phase 1A

APR Applied Pharma Research s.a.

1 program

Phase 2Pacira Pharmaceuticals, Inc logo

Pacira Pharmaceuticals, Inc

1 program

Phase 2Biogen logo

Biogen

1 program

Phase 2C

Cerimon Pharmaceuticals

1 program

Phase 3Novartis logo

Novartis

1 program

Phase 3

Pipeline

Programs by Phase

Analysis

Modality Breakdown

96%

Small molecule

23 of 24 classified programs — the dominant modality here.

4%ALL OTHERSProtein / enzyme14%

Small molecule leads; the ring shows all 24 classified programs, each share of the total. Modality classified for 100% of 25 pipeline programs.

Analysis

Trial Status

19

clinical trials

Completed13 · 68%
Unknown status3 · 16%
Not yet recruiting2 · 11%
Terminated1 · 5%

Clinical Trials

Trial Activity

19 trials

Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis
Not yet recruiting·TTaipei Medical University·Phase 4·NCT06508125·52 enrolled
Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis
Not yet recruiting·SShin Kong Wu Ho-Su Memorial Hospital·Phase 4·NCT06935877·60 enrolled
Efficacy of Neural Prolotherapy for Treatment of Anserine Bursitis "NPCAB"
Completed·UUniversity of Alexandria·N/A·NCT04509440·43 enrolled
A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee
Completed·AAPR Applied Pharma Research s.a.·Phase 2·NCT00903994·17 enrolled
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
Completed·TThe University of Texas Health Science Center, Houston·Phase 2·NCT04182672·22 enrolled
Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Completed·UUniversidad Autonoma de Nuevo Leon·Phase 2·NCT01205477·58 enrolled
Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis
Completed·CCerimon Pharmaceuticals·Phase 2/3·NCT00640939·308 enrolled
Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis
Completed·KKeesler Air Force Base Medical Center·N/A·NCT01830699·33 enrolled
Steroid Injection with Exercise for Subacromial Bursitis
Completed·TTaipei Medical University Shuang Ho Hospital·N/A·NCT06220643·60 enrolled
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
Completed·MMEDRx USA, Inc.·Phase 3·NCT01161615·350 enrolled
Efficacy of Corticosteroid and Local Anesthetic Injections Patients With Concomitant Pes Anserine Bursitis
Completed·—·N/A·NCT04887844·102 enrolled
Effect of Combined Ultrasound-guided Subdeltoid Corticosteroid Injections and Physiotherapy in Treatment of Patients With Chronic Subacromial Bursitis
Completed·SShin Kong Wu Ho-Su Memorial Hospital·N/A·NCT03871465·111 enrolled
Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis
Completed·KKeesler Air Force Base Medical Center·N/A·NCT02242630·61 enrolled
Effect of Ultrasound-guided Hyaluronic or Corticosteroid Injections in Patients With Chronic Subacromial Bursitis
Completed·SShin Kong Wu Ho-Su Memorial Hospital·N/A·NCT02702206·207 enrolled
Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
Completed·AAPR Applied Pharma Research s.a.·Phase 3·NCT00352625·330 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)